
About Startell Bioceuticals Private Limited
Data last updated:
Startell Bioceuticals Private Limited is a private limited company based in Majiwada, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 April 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U52394MH2016PTC280155. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹35 Lakh and a paid-up capital of ₹35 Lakh. It is led by directors Nilesh Ramesh Sarode and Bijal Kalpesh Desai.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Office No.1 Ground Floor New Hill View Chsl Behind Sachinam Tower., Majiwada, Maharashtra, India – 400601.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.08 Cr, a growth of 30% compared to the previous year. For the same year it recorded a net profit of ₹8.14 Lakh (net margin 1.1%) and EBITDA of ₹17.06 Lakh (EBITDA margin 2.4%). Revenue has declined at a compounded annual rate (CAGR) of 18% over three years and 1% over five years.
The company has about 51 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Startell Bioceuticals. As per MCA filings, the company has open charges of ₹67 Lakh on record. Court records list 2 cases involving the company, including 2 filed against it; 2 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website startellbio.com.
Company details
Contact details
Startell Bioceuticals Private Limited's registered office is in Majiwada, Maharashtra. Its website is startellbio.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressOffice No.1 Ground Floor New Hill View Chsl Behind Sachinam Tower., Majiwada, Maharashtra, India – 400601
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Startell Bioceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Startell Bioceuticals operates one associated brand: Startell Bioceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and distributing innovative pharmaceutical medicines in India and the USA. | startellbio.com |
Business activity
The main business activity of Startell Bioceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles |
To see the full business activity and turnover split of Startell Bioceuticals Private Limited, buy the company report.
Financials of Startell Bioceuticals Private Limited
FY 2025 filings availableStartell Bioceuticals Private Limited reported revenue of ₹7.08 Cr (up 30% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 30% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 1%. EBITDA rose 137% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹17.06 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.14 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.4% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Startell Bioceuticals Private Limited, buy the company report.
Board of directors of Startell Bioceuticals Private Limited
Startell Bioceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nilesh Ramesh Sarode Also directs: Startell Medical Management Services LLP, Sani Multitrades Private Limited, Inways Multitrade Private Limited and 1 more | Director | 05 May 2025 | 1 Years 6 Months | Current |
| Bijal Kalpesh Desai Also directs: Startell Medical Management Services LLP | Director | 25 Apr 2016 | 10 Years 6 Months | Current |
Auditor
Startell Bioceuticals Private Limited is audited by JELVIS HENRIQUES & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JELVIS HENRIQUES & CO | FY 2023 | 127844W |
Shareholding
The shareholding of Startell Bioceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Startell Bioceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 02 Aug 2019 | 100283813 | Others | ₹67 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Startell Bioceuticals Private Limited has 2 court cases on record: 2 filed against it. All cases are pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 2 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Thane, Maharashtra | Civil suit | Filed against the company by Food and Drugs Administration M.S. Thane Drugs Inspector Rajesh Baburao Bankar | Pending |
| District court, SURAT, Gujarat | Court case (SMCST) | Filed against the company by an individual | Pending |
To see the full case history of Startell Bioceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Startell Bioceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Startell Bioceuticals Private Limited has a workforce of 51 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 51 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Startell Bioceuticals Private Limited, buy the company report.
GST
Startell Bioceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Startell Bioceuticals Private Limited, buy the company report.
Recent activity
Startell Bioceuticals Private Limited has 5 board changes on record since 2016: 2 appointments and 3 cessations. The latest: Santosh Vidyasagar Dube ceased to be Director on 16 May 2025.
Frequently asked questions
Startell Bioceuticals is an active private limited company based in Majiwada, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 April 2016 (10+ years old) and is registered under CIN U52394MH2016PTC280155.
Startell Bioceuticals has 2 current directors:
- Nilesh Ramesh Sarode - Director
- Bijal Kalpesh Desai - Director
The latest financial statements of Startell Bioceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
No. Startell Bioceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Startell Bioceuticals is U52394MH2016PTC280155. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Startell Bioceuticals has 2 court cases on record: 2 filed against it. 2 are pending.
Startell Bioceuticals was incorporated on 25 April 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
Santosh Vidyasagar Dube ceased to be Director on 16 May 2025. Nilesh Ramesh Sarode was appointed as Director on 05 May 2025. Ashish Vidyasagar Dube ceased to be Director on 28 Jul 2016. Startell Bioceuticals has 5 board changes on record in total.
Startell Bioceuticals can be reached through the website startellbio.com. Its registered office is in Majiwada, Maharashtra, India.
The registered office of Startell Bioceuticals is at Office No.1 Ground Floor New Hill View Chsl Behind Sachinam Tower., Majiwada, Maharashtra, India – 400601.

